Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
David Zidar, MD, PhD

David Zidar, MD, PhD

  • Specialty: Cardiology, Cardiology-Interventional Cardiology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Cleveland Medical Center Mather (0 mi.)

11100 Euclid Ave
Mather Ste 1800
Cleveland, OH 44106

Biography: David Zidar, MD, PhD


  • Acute Coronary Syndromes
  • Cardiac Catheterization
  • Cardiovascular Medicine
  • Endovascular Procedures
  • Familial Hypercholesterolemia
  • Immunology
  • Interventional Cardiology
  • Peripheral Arterial Disease
  • Peripheral Vascular Diseases


  • Assistant Professor, CWRU School of Medicine

Certifications & Memberships

  • Interventional Cardiology - American Board of Internal Medicine
  • Cardiovascular Disease - American Board of Internal Medicine


Fellowship | Interventional Cardiology
Interventional Cardiology - Duke University Hospital (2009 - 2010)

Fellowship | Cardiovascular Disease
Cardiovascular Disease - Duke University Hospital (2001 - 2009)

Residency | Internal Medicine
Internal Medicine - Johns Hopkins Hospital (1998 - 2001)

Other Education
Duke University (2009)

Medical Education
Duke University School Of Medicine (1998)

Notre Dame College (1994)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, David Zidar disclosed the following Outside Relationships with Industry:

  • - AstraZeneca - Other
  • - Medtronic - Honoraria